The Intersection Of Venture Capital And Private Equity Investing April 12th, 2017Events & Associations Events In recent years, there has been a convergence of investment strategies in the lower middle market. Venture capital and leveraged buyout firms are increasingly playing in each other’s traditional markets, to varying degrees of success. This panel discussion will feature firms making later-stage, growth-oriented VC investments (control and minority), as well as buyouts and majority deals. Panelists will discuss their approaches to investing in companies at the intersection of growth and buyout. Panelists: Mark Buffington – CEO and Co-Founder, BIP Capital Jim Douglass – Partner, Fulcrum Equity Partners Ed Fisher – Founder and Managing Partner, Read More
Top Takeaways from HIMSS and the Opportunities in Health IT for 2017 March 13th, 2017Health IT Events Morris, Manning & Martin, LLP and the Metro Atlanta Chamber bring together a panel of experts to share their takeaways from HIMSS and discuss the opportunities in Health IT for 2017. Panelists •Kornelius Bankston – Director of Bioscience Ecosystem Expansion, Metro Atlanta Chamber •Justin Barnes – Healthcare Innovation & Services Strategist •E Jane Caraway – Director, Georgia Department of Economic Development •Dr. Denise Hines – CEO of eHealth Services Group & Executive Director of GaHIN •Michele Madison – Partner, Morris, Manning & Martin, LLP (Moderator) Read More
The Telephone Consumer Protection Act: What Every Counsel Should Know to Avoid Surprise Liability February 16th, 2017Events & Associations Events The federal Telephone Consumer Protection Act governs when and under what conditions a company or non-profit organization may call a person’s telephone number using an automated telephone dialing system or a prerecorded message. The damages for violation of the TCPA can be substantial, based on $500 per improper call on a strict liability basis. This program covers: (1) the requirements for obtaining consent to call a person using an automated dialing system or prerecorded message (2) the most recent case law examining the types of equipment which qualify as an automated dialing system (3) Read More
Prediction #2 of 5: “Private Equity Investing will be vibrant in the Southeast” January 17th, 2017MMM Tech Perspectives, Private Equity By John Yates & David Calhoun / Corporate Technology Group – Morris, Manning & Martin, LLP We’ve just completed a strong year for technology companies in the Southeast with the wind at our backs moving into 2017. Our law firm closed more than 50 tech M&A and growth equity/venture capital financings in the last 12 months, so we’ve witnessed a number of entrepreneurial successes in 2016. Optimistic 2017 for Atlanta/SE Tech — Heading into the new year, the unknowns are greater than ever, but if the momentum continues, it’s realistic to predict another very strong year for technology entrepreneurs in Atlanta and Read More
Georgia vs. Florida – The Game of VC Financing December 29th, 2016MMM Tech Perspectives Georgia vs. Florida – The Game of VC Financing The Georgia vs. Florida football game is a traditional rivalry for football dominance in the Southeast. In honor of the upcoming game, let’s explore how these two states compare in creating an environment for entrepreneurs to raise venture capital. 1. Florida is one of the most populous states in the U.S. (fourth in the nation) but is lagging in venture capital investment. Q2 2014 saw 13 deals with investments around $112.9 million (a drop from Q2 Read More
Making the Jump to CEO: Leadership Insights from Women CEOs November 2nd, 2016Entrepreneurial Info, Events & Associations Events Join Frazier & Deeter and Morris, Manning & Martin, LLP for a unique panel discussion regarding the leadership transition from being a function leader within a large organization to running the company. What are the biggest challenges? What were the greatest lessons learned along the way when these highly accomplished women made the move to CEO? Featuring Dr. Amy Baxter, Founder & CEO, MMJ Labs Dr. Baxter directs innovation, invention, operations and strategy for MMJ Labs Personal Pain Relief. Accomplishments include the 2009 1.1M NIH SBIR and Read More
Drone Law Seminar November 2nd, 2016Drones/UAV Events Operating a drone, even a small one for recreational purposes, has legal implications for the operator and owner. Commercial operators have greater restrictions. These range from operational regulations and restrictions under Federal and State law, to privacy, trespass and nuisance issues, to tort liability for damage to property or individuals. Staying out in front of this technological wave is a business imperative: Business Insider adjusted its estimates of the drone market in 2020-21 from $1 billion in a 2014 report to $12 billion in a recent report. The Seminar Read More
MACRA: How IT Can Support Physician Reimbursement October 19th, 2016Health IT Events The Medicare Access and CHIP Re-authorization Act (“MACRA”) aims to change up the reimbursement landscape. MACRA intends to transform the fee-for-service system to a value-based and quality model. This Event will Review the details of the two payment models proposed under MACRA; specifically, the Medicare Incentive Based Payment System (“MIPS”) and the Alternative Payment Models (“APMs”) and how information technology or practice activities can support Physician reimbursement from Medicare. New regulations can be confusing and frustrating. Join TAG Health and a panel of industry experts as we breakdown this new regulation. Panelists: •Sherry Read More
Health Futures Forum: Congress, Commerce and Care October 10th, 2016Events & Associations, Health IT Events In this Health Futures Forum session, we engage leading voices from three critical dimensions of influence on the future of Health – governmental, market innovation and the training and delivery of health services. The nexus of these three worlds offer significant insight on the future enrichment of health of individuals and our society. The 21st century offers exceptional opportunities in science, process innovation and awareness of health possibilities. It is incumbent on all relevant parties to address the challenges faced by the traditional venues of health assistance. Research, methods and processes all transform Read More
Commercial Offer For Sale Does Not Include Third Party Manufacturing Services July 18th, 2016Life Sciences/Pharma By Mary An Merchant, PhD & Richard T. Timmer The biopharmaceutical world breathed a collective sigh of relief when the Court of Appeals for the Federal Circuit (“CAFC”) issued its ruling regarding the “on sale bar” as it relates to patent eligibility. In the ruling on Monday, July 11, 2016, the CAFC in The Medicines Company v. Hospira, Inc.(CAFC Case No. 2014-1469, 2014-1504) affirmed the district court ruling and held that to be “on sale” under 35 U.S.C. § 102(b), “a product must be the subject of a commercial sale or offer Read More